Delivery Order SPE2DB22D2009-SPE2DB25FM1NY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Chloraseptic Max 15-10 mg lozenges in quantities of 15 units. This is a firm fixed-price delivery order with a ceiling value of $2,636.76 and an ultimate completion date of August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,119.84 for Chloraseptic sore throat lozenges (18-count). This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. The order will be performed in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.30 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages). Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying...
- The Defense Logistics Agency awarded a delivery order valued at $5,855.84 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18 count) on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed price contract, which received no set-aside designation, was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,020.52 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Chloraseptic Sore Throat Lozenges (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of June 18, 2025, and no set-aside designation was applied to this competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,221.75 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18 count). The contract is a firm fixed-price delivery order with no set-aside designation, executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,290.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages) on June 2, 2025, with an ultimate completion date of June 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,029.95 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Chloraseptic Sore Throat Lozenges (18-count package). This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1NYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-count) under a firm fixed-price contract valued at $3,864.64, with an ultimate completion date of September 18, 2025. This non-set-aside award was issued competitively and represents a single delivery order for over-the-counter throat lozenges to support federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to the Defense Health Agency and other military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen leverages this IDC vehicle to supply a broad range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic categories to support federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/17/25 |